UNH Stock: The Recovery Is Real. Is It Already Priced In? — Q3 2026

UnitedHealth Group Incorporated (UNH) Q3 2026 — UNH traded at $410.12 on October 15 at 17:56 UTC, up 3.67% versus the prior $395.62 close; this is a frozen intraday snapshot, not the earnings-day closing return.

UnitedHealth reported higher profit on slightly lower revenue and raised its annual earnings floor. We separate medical reserve development and portfolio benefits from recurring operating progress, then test whether the valuation leaves enough protection.

THE CALL: HOLD (3/5, MODERATE) — base-case value ~$400.00 vs ~$410.12 today.

KEY METRICS:

- Q3 revenue $112,694M, −0.4% YoY; operating earnings $6,563M, +52.1%

- GAAP EPS $4.56; adjusted EPS $4.69

- FY2026 adjusted EPS guidance at least $20.50

- Reported medical care ratio 88.4%; favorable medical reserve development $610M

- Optum Health adjusted operating margin 2.6%; medical members 48.3M

- Nine-month operating cash $25,087M; capex $2,421M; computed conventional FCF $22,666M

- Debt-to-capital 41.7%; company year-end target approximately 40%

What to watch: Medical economics hold with less reserve support, Optum Health adjusted margins improve and capital targets are met; otherwise require a larger valuation cushion.